Browsing Tag
NASDAQ
475 posts
Is Nextpower becoming more than a solar tracker stock after the Prevalon deal?
Find out how Nextpower’s Prevalon deal could reshape solar-plus-storage growth, AI data center power, and NXT stock sentiment today.
Meta Platforms wants AI wearables at work, but can Reality Labs finally make hardware pay?
Meta wants AI wearables at work, but privacy and Reality Labs losses loom. Read why the pendant plan matters now.
SpaceX reportedly trims IPO valuation target to $1.8tn as Musk disputes the figure
Bloomberg says SpaceX cut its IPO target to $1.8T while raising up to $75B, but Musk calls it false. Inside the financials behind the largest listing in history.
Is Meta Platforms training AI agents on the workplace data regulators fear most?
Meta wants workplace data for AI agents, but Europe may test the privacy limits. Read why this could reshape Big Tech’s AI playbook.
Quantinuum IPO oversubscribed as Honeywell-backed quantum firm targets a $12.7bn valuation
Quantinuum's IPO is oversubscribed many times over at a $12.7B target valuation on just $31M of revenue, as Honeywell unlocks value and the quantum trade heats up.
Can CoStar’s Zonda deal turn new-home data into its next residential growth weapon?
CoStar’s reported $800M Zonda deal could deepen its housing data moat. See why new-home intelligence matters now.
Beneath the semiconductor rally, Qualcomm faces erosion as Wolfspeed rides an AI repricing
Qualcomm and Wolfspeed fell together in a chip selloff, but one faces Apple share loss and the other is an AI-driven turnaround as Marvell sets a record. Read more.
Jensen Huang moves to lock in Nvidia ($NVDA), SK hynix and TSMC as the AI memory and logic axis
As memory becomes the AI bottleneck, Jensen Huang moves to lock in Nvidia, SK hynix, and TSMC supply while committing $150B a year to Taiwan. Read more.
Corcept Therapeutics (NASDAQ: CORT) climbs 7% as Lifyorli launch and analyst upgrades drive cortisol re-rating
Corcept turned a stress hormone into an ovarian cancer drug. Lifyorli is launching fast and analysts are chasing, but a premium multiple prices in a lot.
Could Russell index inclusion strengthen long-term investor confidence in Opendoor Technologies Inc. (NASDAQ: OPEN)?
Find out why Opendoor Technologies Inc.’s Russell 3000 inclusion could reshape institutional sentiment around OPEN stock and housing technology.